Premature Neonate | Medical XPRT
News
-
Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions, announced today that the Food and Drug Administration (FDA) has granted it's lead ...
Equipment & Solutions
-
Showcase
Infant Warmer for Newborn
The care of ill or premature newborn infants. Technological monitoring and WARMING therapy mean special care for babies.